Shanwen Chen
- Topics
- Bladder and Urothelial Cancer Treatments (7 papers)Urinary and Genital Oncology Studies (4 papers)MicroRNA in disease regulation (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Shanwen Chen
21 papers receiving 440 citations
Peers
Comparison fields: 5 of 66
- Surgery 251
- Pulmonary and Respiratory Medicine 180
- Molecular Biology 96
- Cancer Research 74
- Oncology 68
Countries citing papers authored by Shanwen Chen
This map shows the geographic impact of Shanwen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanwen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanwen Chen more than expected).
Fields of papers citing papers by Shanwen Chen
This network shows the impact of papers produced by Shanwen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanwen Chen. The network helps show where Shanwen Chen may publish in the future.
Co-authorship network of co-authors of Shanwen Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Shanwen Chen. A scholar is included among the top collaborators of Shanwen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanwen Chen. Shanwen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 26 | |
| 5 | 46 | |
| 6 | 12 | |
| 7 | 21 | |
| 8 | 13 | |
| 9 | MicroRNA-195 inhibits epithelial-mesenchymal transition via downregulating CDK4 in bladder cancer. | 5 |
| 10 | 17 | |
| 11 | 20 | |
| 12 | 49 | |
| 13 | 1 | |
| 14 | 10 | |
| 15 | 16 | |
| 16 | 4 | |
| 17 | 7 | |
| 18 | 96 | |
| 19 | 10 | |
| 20 | 22 |
About Shanwen Chen
Shanwen Chen is a scholar working on Urology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 22 papers that have together received 450 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Urology (47 citations), Surgery (251 citations) and Pulmonary and Respiratory Medicine (180 citations). Shanwen Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhoujun Shen, Tianyuan Xu, Yifan Shen, Fan Dong, Shan Zhong, Fengbin Gao, Ming Li, Yangyan He, Ziheng Wu and Wei� Jin. Their work appears in journals such as The Journal of Urology, Urology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.